BioInfra Co., Ltd. (KOSDAQ:199730)

BioInfra Statistics

Total Valuation

BioInfra has a market cap or net worth of KRW 15.15 billion. The enterprise value is 19.57 billion.

Market Cap	15.15B
Enterprise Value	19.57B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 29, 2025

Share Statistics

BioInfra has 4.86 million shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class	4.86M
Shares Outstanding	4.86M
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	51.38%
Owned by Institutions (%)	n/a
Float	2.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.65
PB Ratio	1.21
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.98
EV / Sales	0.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.74

Financial Position

The company has a current ratio of 0.59, with a Debt / Equity ratio of 1.01.

Current Ratio	0.59
Quick Ratio	0.53
Debt / Equity	1.01
Debt / EBITDA	n/a
Debt / FCF	-6.32
Interest Coverage	-17.65

Financial Efficiency

Return on equity (ROE) is -54.29% and return on invested capital (ROIC) is -34.90%.

Return on Equity (ROE)	-54.29%
Return on Assets (ROA)	-10.72%
Return on Invested Capital (ROIC)	-34.90%
Return on Capital Employed (ROCE)	-48.79%
Weighted Average Cost of Capital (WACC)	4.17%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.61
Inventory Turnover	n/a

Taxes

In the past 12 months, BioInfra has paid 1.50 billion in taxes.

Income Tax	1.50B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.66% in the last 52 weeks. The beta is 0.27, so BioInfra's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-46.66%
50-Day Moving Average	3,913.50
200-Day Moving Average	4,563.85
Relative Strength Index (RSI)	20.53
Average Volume (20 Days)	11,555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioInfra had revenue of KRW 23.21 billion and -9.89 billion in losses. Loss per share was -2,031.97.

Revenue	23.21B
Gross Profit	5.29B
Operating Income	-6.48B
Pretax Income	-8.39B
Net Income	-9.89B
EBITDA	-2.99B
EBIT	-6.48B
Loss Per Share	-2,031.97

Balance Sheet

The company has 8.28 billion in cash and 12.70 billion in debt, with a net cash position of -4.42 billion or -908.05 per share.

Cash & Cash Equivalents	8.28B
Total Debt	12.70B
Net Cash	-4.42B
Net Cash Per Share	-908.05
Equity (Book Value)	12.54B
Book Value Per Share	2,577.80
Working Capital	-8.69B

Cash Flow

In the last 12 months, operating cash flow was -808.74 million and capital expenditures -1.20 billion, giving a free cash flow of -2.01 billion.

Operating Cash Flow	-808.74M
Capital Expenditures	-1.20B
Depreciation & Amortization	3.49B
Net Borrowing	1.51B
Free Cash Flow	-2.01B
FCF Per Share	-412.97

Margins

Gross margin is 22.81%, with operating and profit margins of -27.92% and -42.60%.

Gross Margin	22.81%
Operating Margin	-27.92%
Pretax Margin	-36.14%
Profit Margin	-42.60%
EBITDA Margin	-12.87%
EBIT Margin	-27.92%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 9.42%.

Dividend Per Share	300.00
Dividend Yield	9.42%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.08%
Shareholder Yield	9.34%
Earnings Yield	-65.25%
FCF Yield	-13.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioInfra has an Altman Z-Score of 0.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.54
Piotroski F-Score	3